153 related articles for article (PubMed ID: 17048524)
1. Bioadhesive properties of poly(alkylcyanoacrylate) nanoparticles coated with polysaccharide.
Bertholon I; Ponchel G; Labarre D; Couvreur P; Vauthier C
J Nanosci Nanotechnol; 2006; 6(9-10):3102-9. PubMed ID: 17048524
[TBL] [Abstract][Full Text] [Related]
2. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
[TBL] [Abstract][Full Text] [Related]
3. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush.
Labarre D; Vauthier C; Chauvierre C; Petri B; Müller R; Chehimi MM
Biomaterials; 2005 Aug; 26(24):5075-84. PubMed ID: 15769543
[TBL] [Abstract][Full Text] [Related]
4. Bioadhesive properties of poly(anhydride) nanoparticles coated with different molecular weights chitosan.
Llabot JM; Salman H; Millotti G; Bernkop-Schnürch A; Allemandi D; Manuel Irache J
J Microencapsul; 2011; 28(5):455-63. PubMed ID: 21561241
[TBL] [Abstract][Full Text] [Related]
5. Preparation, intestinal segment stability, and mucoadhesion properties of novel thymopentin-loaded chitosan derivatives coated with poly (n-butyl) cyanoacrylate nanoparticles.
Xu Y; Lu S; Liu Q; Hong Y; Xu B; Ping Q; Jin X; Shen Y; Webster TJ; Rao Y
Int J Nanomedicine; 2019; 14():1659-1668. PubMed ID: 30880971
[TBL] [Abstract][Full Text] [Related]
6. Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide.
Bertholon I; Vauthier C; Labarre D
Pharm Res; 2006 Jun; 23(6):1313-23. PubMed ID: 16715369
[TBL] [Abstract][Full Text] [Related]
7. The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticles on mucoadhesion due to pluronic F68 addition.
Petit B; Bouchemal K; Vauthier C; Djabourov M; Ponchel G
Pharm Res; 2012 Apr; 29(4):943-52. PubMed ID: 22146804
[TBL] [Abstract][Full Text] [Related]
8. Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier.
Chauvierre C; Marden MC; Vauthier C; Labarre D; Couvreur P; Leclerc L
Biomaterials; 2004 Jul; 25(15):3081-6. PubMed ID: 14967542
[TBL] [Abstract][Full Text] [Related]
9. Properties of polysaccharides grafted on nanoparticles investigated by EPR.
Bertholon I; Hommel H; Labarre D; Vauthier C
Langmuir; 2006 Jun; 22(12):5485-90. PubMed ID: 16732681
[TBL] [Abstract][Full Text] [Related]
10. Bioadhesive mannosylated nanoparticles for oral drug delivery.
Salman HH; Gamazo C; Campanero MA; Irache JM
J Nanosci Nanotechnol; 2006; 6(9-10):3203-9. PubMed ID: 17048537
[TBL] [Abstract][Full Text] [Related]
11. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.
Inchaurraga L; Martín-Arbella N; Zabaleta V; Quincoces G; Peñuelas I; Irache JM
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):280-9. PubMed ID: 25541441
[TBL] [Abstract][Full Text] [Related]
12. Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Chacun H; Ponchel G
Eur J Pharm Biopharm; 2008 Jun; 69(2):436-44. PubMed ID: 18395430
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive properties of low molecular weight chitosan- or glycol chitosan- and corresponding thiomer-coated poly(isobutylcyanoacrylate) core-shell nanoparticles.
Palazzo C; Trapani G; Ponchel G; Trapani A; Vauthier C
Eur J Pharm Biopharm; 2017 Aug; 117():315-323. PubMed ID: 28455206
[TBL] [Abstract][Full Text] [Related]
14. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
Sheng Y; He H; Zou H
Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
[TBL] [Abstract][Full Text] [Related]
15. Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles.
Porfire AS; Zabaleta V; Gamazo C; Leucuta SE; Irache JM
Int J Pharm; 2010 May; 390(1):37-44. PubMed ID: 19712734
[TBL] [Abstract][Full Text] [Related]
16. Bioadhesive characteristics of chitosan microspheres to the mucosa of rat small intestine.
Shimoda J; Onishi H; Machida Y
Drug Dev Ind Pharm; 2001 Jul; 27(6):567-76. PubMed ID: 11548864
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery.
Iglesias T; López de Cerain A; Irache JM; Martín-Arbella N; Wilcox M; Pearson J; Azqueta A
Int J Pharm; 2017 Jan; 517(1-2):67-79. PubMed ID: 27908629
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles.
Yoncheva K; Guembe L; Campanero MA; Irache JM
Int J Pharm; 2007 Apr; 334(1-2):156-65. PubMed ID: 17118588
[TBL] [Abstract][Full Text] [Related]
19. Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosa.
Pradines B; Bories C; Vauthier C; Ponchel G; Loiseau PM; Bouchemal K
Pharm Res; 2015 Apr; 32(4):1229-36. PubMed ID: 25319099
[TBL] [Abstract][Full Text] [Related]
20. Human vascular endothelial cells in primary cell culture for the evaluation of nanoparticle bioadhesion.
Löhbach C; Neumann D; Lehr CM; Lamprecht A
J Nanosci Nanotechnol; 2006; 6(9-10):3303-9. PubMed ID: 17048551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
